2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint.
Sök 2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint. 2cureX announced today that its prospective interventional clinical trial investigating the benefit of IndiTreat®-guided treatment achieved its primary endpoint by improving Progression Free Survival (PFS) after eight weeks of treatment. Full data has been submitted to the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. 2cureX Publicerad: 1 mars 2021, 13:00 “These results show there’s a significant improvement for patients when trea...
Source: di.se